ID Week

Shorts

Ancillary Benefits of Clinical Trials
0:22
Ancillary Benefits of Clinical Trials
14 days ago
by
Arif R. Sarwari, MD, MSc, MBA(+1 more)
Conducting Trials in Rural Areas
0:22
Conducting Trials in Rural Areas
19 days ago
by
Arif R. Sarwari, MD, MSc, MBA(+1 more)
Do the New Hepatitis B Birth Dose Guidelines Miss Horizontal Transmission?
0:35
Do the New Hepatitis B Birth Dose Guidelines Miss Horizontal Transmission?
23 days ago
by
Karen B. Jacobson, MD, MPH(+1 more)
Why Preserving Amikacin and Macrolide Susceptibility Matters in MAC Lung Disease
0:32
Why Preserving Amikacin and Macrolide Susceptibility Matters in MAC Lung Disease
23 days ago
by
Kevin Winthrop, MD(+1 more)
Hepatitis B’s Hidden Household Risk for Infants
1:11
Hepatitis B’s Hidden Household Risk for Infants
24 days ago
by
Karen B. Jacobson, MD, MPH(+1 more)
Should You Test MAC Isolates for Susceptibility Every Time?
0:52
Should You Test MAC Isolates for Susceptibility Every Time?
24 days ago
by
Kevin Winthrop, MD(+1 more)
Why the Hepatitis B Birth Dose Is the Most Feasible Protection
0:33
Why the Hepatitis B Birth Dose Is the Most Feasible Protection
25 days ago
by
Karen B. Jacobson, MD, MPH(+1 more)
Why ENCORE Tested Inhaled Amikacin From the Start of MAC Treatment
0:36
Why ENCORE Tested Inhaled Amikacin From the Start of MAC Treatment
25 days ago
by
Kevin Winthrop, MD(+1 more)

Latest Content

After the Clinical and Laboratory Standards Institute (CLSI) revised their clinical breakpoints for susceptibility test results, a laboratory at a major medical center in a large midwest city evaluated enterobacterales as it relates to bloodstream infections (BSI) and piperacillin/tazobactam.

After Helen Boucher, MD, gave the Maxwell Finland presentation she spoke of the continuing issues as well as the encouraging aspects that have institutions working on the problem.

There is an evolution of thinking about how this is treated and investigational therapies are looking to help these patients improve not only their medical conditions but give them back their quality-of-life.